Skip to Content

Arrowhead Pharmaceuticals Inc ARWR Stock Quote

| Rating as of

NASDAQ:ARWR

Morningstar‘s Stock Analysis ARWR

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics ARWR

Company Profile ARWR

Business Description

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Contact
177 E. Colorado Boulevard, Suite 700
Pasadena, CA, 91105
T +1 626 304-3400
Industry Biotechnology
Most Recent Earnings Sep 30, 2022
Fiscal Year End Sep 30, 2023
Employees 397